Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Stagezero Life Sciences Ltd (SZLSF)

Stagezero Life Sciences Ltd (SZLSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,335
  • Shares Outstanding, K 123,533
  • Annual Sales, $ 3,800 K
  • Annual Income, $ -11,420 K
  • 60-Month Beta 0.61
  • Price/Sales 1.11
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SZLSF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.12
  • Most Recent Earnings $-0.01 on 11/14/23
  • Latest Earnings Date 05/20/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0256 +56.25%
on 04/24/24
0.0400 unch
on 04/24/24
+0.0069 (+20.85%)
since 03/22/24
3-Month
0.0256 +56.25%
on 04/24/24
0.0400 unch
on 04/24/24
+0.0112 (+38.89%)
since 01/19/24
52-Week
0.0256 +56.25%
on 04/24/24
0.0610 -34.43%
on 07/10/23
-0.0233 (-36.81%)
since 04/19/23

Most Recent Stories

More News
StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024

Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting

Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - StageZero Life Sciences, Ltd (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call

Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special and...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational Update

Toronto, Ontario--(Newsfile Corp. - May 16, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023

Toronto, Ontario--(Newsfile Corp. - May 15, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its first quarter 2023 operational results after...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update

Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero to Issue Q4 2022 Financial Results on Friday March 31

Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
Results from METRICs Study Informs Expansion of StageZero's New Care Oncology Protocol

Launch of New Protocol will now make the connection between patients' metabolic health and cancer outcomes using advanced biomarker testing and interactive digital health platform to actively track patient...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero Life Sciences Announces Change of Date of Special Meeting of Shareholders; Will Combine with AGM in Q2 2023

Toronto, Ontario--(Newsfile Corp. - February 2, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)

Business Summary

StageZero Life Sciences Ltd is dedicated to the early detection of cancer and multiple disease states through whole blood. The company's test consists of Aristotle(R), a multi-cancer panel for simultaneously screening for cancers from a single sample of blood. StageZero Life Sciences Ltd, formerly known...

See More

Key Turning Points

3rd Resistance Point 0.0270
2nd Resistance Point 0.0270
1st Resistance Point 0.0270
Last Price 0.0400
1st Support Level 0.0270
2nd Support Level 0.0270
3rd Support Level 0.0270

See More

52-Week High 0.0610
Fibonacci 61.8% 0.0475
Fibonacci 50% 0.0433
Last Price 0.0400
Fibonacci 38.2% 0.0391
52-Week Low 0.0256

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar